Featured Insights

  1. Improving Access And Support For Cell And Gene Therapies 10/9/2023

    Although cell and gene therapies (CGTs) are potentially transformative, their effectiveness is undermined by difficulties with patient access and support, high costs, and a complex pathway to treatment.

  2. Crafting An Effective Commercialization Strategy For CGTs 10/25/2023

    Patient access and manufacturing efficiency persist as barriers to widespread adoption of CGTs. An effective commercialization strategy is crucial to expand access to these life-changing therapies.

  3. A Year Of Reflection And Preparation 1/3/2025

    The Trial Master File (TMF) landscape in 2025 will require companies to stay attuned to the evolving ICH E6(R3) guidelines and the full implementation of the CTIS.

  4. How Patient-Centric Approaches Are Shaping The Future Of CGT 8/6/2024

    Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.

  5. A Comparative Guide To CGTs: Modalities, Landscape, And Logistics 2/29/2024

    Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy

  6. A Thoughtful Copay Program Design That Increased Patient Engagement 11/26/2024

    Learn how a partnership with a pharmaceutical company to redesign patient support materials resulted in increased patient engagement and copay program utilization.

  7. Sterility Assurance With Louise Ui Fhatharta 1/17/2025

    This discussion explores critical aspects of maintaining sterility in pharmaceutical manufacturing, from facility design and environmental monitoring to regulatory compliance and common misconceptions.

  8. The Evolution Of The Cell And Gene Therapy Field 9/29/2023

    Lung-I Cheng, Vice President, Cell and Gene Therapy, AmerisourceBergen, discusses emerging trends in the CGT market and details the value of leveraging the expertise of knowledgeable partners and stakeholders.

  9. Essential Guide To Cell And Gene Therapy Commercialization 10/10/2023

    After devoting time, expertise, and financial resources to developing a transformative cell or gene therapy, it is essential to ensure patients can receive all of the benefits of your innovation.

  10. Evolving And Expanding Global Consulting With Local Expertise 2/3/2025

    Experts discuss global market expansion, emphasizing regulatory complexities, product lifecycle investments, and integrating local expertise to ensure successful product launches and long-term market sustainability.